Top Markets
Coin of the day
Imaging Biometrics Ltd. Imaging Biometrics Ltd.

Imaging Biometrics Ltd.

IBAI
Classement en actions #41258
Imaging Biometrics Ltd., founded in 1965 and headquartered in Saint Helier,... Imaging Biometrics Ltd., founded in 1965 and headquartered in Saint Helier, Jersey, specializes in medical imaging diagnostics and clinical patient care. The company extends its services across the United Kingdom, Switzerland, the European Union, and the United States. Its operations are structured into three main segments: a Holding Company, Medical Software, and Oral Gallium Maltolate (GaM). The Medical Software division develops a comprehensive suite of ready-to-use software applications for the healthcare sector. This portfolio includes IB Clinic, which serves as the foundational platform for all IB software; IB Neuro, a specialized platform for MR DSC perfusion processing; and IB Delta Suite, designed to generate Delta T1 maps from routine MR examinations. Further offerings comprise IB DCE and IB Diffusion, both providing in-depth insights into blood flow and water diffusion throughout the body. For non-invasive assessments, the company provides StoneChecker and Liver Surface Nodularity, which are computed tomography (CT) processing tools that assist clinicians in evaluating kidney stones and liver health. Additional software includes IB ASL, used to measure cerebral blood flow for diagnosing conditions like stroke and dementia, and IB Zero G, an innovative technology that eliminates the need for gadolinium contrast agents in standard imaging. The suite also features IB Nimble, facilitating virtual collaboration among healthcare professionals. Beyond software, the company's Oral Gallium Maltolate (GaM) segment is actively pursuing the development of IB003, a gallium maltolate drug candidate currently in Phase 1 clinical trials for treating glioblastoma. Imaging Biometrics Ltd. also offers consulting services. The entity, which was previously known as IQ-AI Limited, is slated to adopt the name Imaging Biometrics Ltd. in May 2025.
Prix de l'action
$0.01197417
Capitalisation boursière
$29.54K
Changement (1 jour)
13.55%
Changement (1 an)
22.84%
Pays
JE
Échange Imaging Biometrics Ltd. (IBAI)

Catégorie

Ratio P/B pour Imaging Biometrics Ltd. (IBAI)
Ratio P/B au September 2026 TTM : 5.94
Selon les derniers rapports financiers et le cours de l'action de Imaging Biometrics Ltd., le ratio cours/valeur comptable actuel (TTM) est 5.94. À la fin de 2023, le ratio P/B était de 90.96.
Historique du ratio P/B pour Imaging Biometrics Ltd. de 2000 à 2026
Ratio P/B à la fin de chaque année
Année Ratio P/B Changez
2026 (TTM) 5.94 -41.09%
2024 10.09 -88.91%
2023 90.96 1,829.77%
2022 4.71 -45.86%
2021 8.71 -38.52%
2020 14.16 364.11%
2019 3.05 15.61%
2018 2.64 -30.60%
2017 3.80 -237.75%
2016 -2.76 -74.64%
2015 -10.89 -242.84%
2014 7.62 1,314.23%
2013 0.54 28.77%
2012 0.42 -58.11%
2011 1.00 -32.16%
2010 1.47 -6.63%
2009 1.58 3.44%
2008 1.53 -19.72%
2007 1.90 -52.96%
2006 4.04 45.33%
2005 2.78 -18.33%
2004 3.40 27.59%
2003 2.67 -12.62%
2002 3.05 7.49%
2001 2.84 -18.50%
2000 3.48 0.00%
Ratio P/B pour des entreprises similaires ou concurrentes
Entreprise Ratio P/B Différence de Ratio P/B Pays
2.652 -55.38%
US
25.1557 323.23%
US
38.3716 545.58%
AU
6.0644 2.03%
US
11.039 85.73%
US